TCG Crossover Management, LLC
- SEC CIK
- 0001839948
- Latest filing
- Aug 14, 2026
TRDA holding history
Entrada Therapeutics, Inc. in every 13F filed by TCG Crossover Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TRDA overviewAll 13F holders of TRDAFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,060,230
- Value
- $7.80M
- % of portfolio
- 0.2%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,060,230 | $7.80M | 0.2% | −1,227,270−53.7% | Reduced | Holders |
| Q1 2026 | 2,287,500 | $28.9M | 0.8% | +199,108+9.5% | Added | Holders |
| Q4 2025 | 2,088,392 | $21.5M | 0.7% | +1,503,437+257.0% | Added | Holders |
| Q3 2025 | 584,955 | $3.39M | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2025 | 584,955 | $3.93M | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2025 | 584,955 | $5.29M | 0.7% | 00.0% | Unchanged | Holders |
| Q4 2024 | 584,955 | $10.1M | 1.0% | 00.0% | Unchanged | Holders |
| Q3 2024 | 584,955 | $9.35M | 0.8% | 00.0% | Unchanged | Holders |
| Q2 2024 | 584,955 | $8.34M | 0.9% | 00.0% | Unchanged | Holders |
| Q1 2024 | 584,955 | $8.29M | 0.7% | 00.0% | Unchanged | Holders |
| Q4 2023 | 584,955 | $8.83M | 1.0% | 00.0% | Unchanged | Holders |
| Q3 2023 | 584,955 | $9.24M | 1.4% | 00.0% | Unchanged | Holders |
| Q2 2023 | 584,955 | $8.86M | 1.5% | 00.0% | Unchanged | Holders |
| Q1 2023 | 584,955 | $8.48M | 1.7% | 00.0% | Unchanged | Holders |
| Q4 2022 | 584,955 | $7.91M | 1.4% | −57,234−8.9% | Reduced | Holders |
| Q3 2022 | 642,189 | $10.1M | 3.0% | −21,505−3.2% | Reduced | Holders |
| Q2 2022 | 663,694 | $8.08M | 3.4% | 00.0% | Unchanged | Holders |
| Q1 2022 | 663,694 | $6.13M | 2.5% | 00.0% | Unchanged | Holders |
| Q4 2021 | 663,694 | $11.4M | 5.3% | – | No prior filing | Holders |